Your browser doesn't support javascript.
loading
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study.
Verbinnen, Thierry; Talloen, Willem; Janssen, Harry L A; Zoulim, Fabien; Shukla, Umesh; Vandenbossche, Joris J; Biermer, Michael; De Meyer, Sandra; Lenz, Oliver.
Affiliation
  • Verbinnen T; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: tverbinn@its.jnj.com.
  • Talloen W; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Janssen HLA; Toronto General Hospital, 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada; Erasmus MC University Hospital Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
  • Zoulim F; INSERM Unit 1052-Cancer Research Institute of Lyon, Hospices Civils de Lyon, Lyon University, 69008, Lyon, France.
  • Shukla U; Janssen Pharmaceuticals Research & Development, LLC 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
  • Vandenbossche JJ; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Biermer M; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • De Meyer S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Lenz O; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340, Beerse, Belgium.
Antiviral Res ; 216: 105660, 2023 08.
Article in En | MEDLINE | ID: mdl-37385475

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic Limits: Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic Limits: Humans Language: En Journal: Antiviral Res Year: 2023 Document type: Article